Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-26-000697
Filing Date
2026-01-06
Accepted
2026-01-06 20:00:09
Documents
1
Period of Report
2026-01-02

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4131
  Complete submission text file 0001493152-26-000697.txt   5590
Mailing Address C/O CONATUS PHARMACEUTICALS INC. 16745 WEST BERNARDO DRIVE, SUITE 200 SAN DIEGO CA 92127
Business Address
Scott Kathleen D. (Reporting) CIK: 0001794284 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40739 | Film No.: 26513581

Mailing Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Issuer) CIK: 0001853816 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)